002044 美年健康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-2.8536.711-7.2570.7697.210
总资产报酬率 ROA (%)-1.1342.673-2.9970.3302.974
投入资产回报率 ROIC (%)-1.3953.339-3.6740.3963.719

边际利润分析
销售毛利率 (%)35.65342.78934.43639.45637.133
营业利润率 (%)-5.6898.112-4.7324.23110.462
息税前利润/营业总收入 (%)-2.25610.530-1.8817.75513.865
净利润/营业总收入 (%)-4.9726.140-5.8221.7278.101

收益指标分析
经营活动净收益/利润总额(%)70.338105.90854.528110.6269.392
价值变动净收益/利润总额(%)8.9045.835-3.42220.346159.520
营业外收支净额/利润总额(%)3.347-4.2049.554-6.901-5.759

偿债能力分析
流动比率 (X)0.7260.7900.7080.8370.962
速动比率 (X)0.7020.7620.6790.8160.945
资产负债率 (%)56.07956.77655.91753.62752.748
带息债务/全部投入资本 (%)34.34133.09033.03333.471--
股东权益/带息债务 (%)140.966149.301151.767152.658110.772
股东权益/负债合计 (%)71.20269.68471.71579.17982.349
利息保障倍数 (X)-0.6213.836-0.5612.0423.490

营运能力分析
应收账款周转天数 (天)122.14388.553107.26899.9680.000
存货周转天数 (天)13.50913.04111.9469.1730.000